Cardiol Therapeutics Files 6-K Report
Ticker: CRDL · Form: 6-K · Filed: 2026-04-10T13:13:00-04:00
Sentiment: neutral
Topics: 6-K, foreign-issuer, disclosure
TL;DR
Cardiol Therapeutics filed a 6-K on 4/10/26. Standard foreign issuer report.
AI Summary
Cardiol Therapeutics Inc. filed a Form 6-K on April 10, 2026, reporting information as a foreign issuer. The filing includes documents such as the 6-K form itself and Exhibit 99.1, along with associated graphics. The company's mailing and business addresses are both located at 602-2265 Upper Middle Road East, Oakville, A6 L6H 0G5.
Why It Matters
This filing provides routine updates and disclosures for Cardiol Therapeutics Inc. as a foreign issuer, which is important for investors tracking the company's compliance and reporting.
Risk Assessment
Risk Level: low — This filing is a routine report of a foreign issuer and does not contain significant new financial or strategic information that would inherently increase risk.
Key Players & Entities
- Cardiol Therapeutics Inc. (company) — Filer
- 0001702123 (company) — CIK Number
- 2026-04-10 (date) — Filing Date
- 602-2265 UPPER MIDDLE ROAD EAST OAKVILLE A6 L6H 0G5 (address) — Mailing and Business Address
FAQ
What type of filing is this?
This is a Form 6-K, which is a report of a foreign issuer.
When was this filing accepted by the SEC?
The filing was accepted on April 10, 2026.
What is the CIK number for Cardiol Therapeutics Inc.?
The CIK number for Cardiol Therapeutics Inc. is 0001702123.
What are the company's mailing and business addresses?
Both the mailing and business addresses are 602-2265 Upper Middle Road East, Oakville, A6 L6H 0G5.
What are the main documents included in this filing?
The filing includes the FORM 6-K itself, EXHIBIT 99.1, and associated graphics.
From the Filing
EDGAR Filing Documents for 0001104659-26-041870 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: SEC Accession No. 0001104659-26-041870 Filing Date 2026-04-10 Accepted 2026-04-10 13:13:00 Documents 3 Period of Report 2026-04-10 Document Format Files Seq Description Document Type Size 1 FORM 6-K tm2611243d1_6k.htm 6-K 9712 2 EXHIBIT 99.1 tm2611243d1_ex99-1.htm EX-99.1 10038 3 GRAPHIC tm2611243d1_ex99-1img001.jpg GRAPHIC 5646 Complete submission text file 0001104659-26-041870.txt 28755 Mailing Address 602-2265 UPPER MIDDLE ROAD EAST OAKVILLE A6 L6H 0G5 Business Address 602-2265 UPPER MIDDLE ROAD EAST OAKVILLE A6 L6H 0G5 289-910-0850 Cardiol Therapeutics Inc. (Filer) CIK : 0001702123 (see all company filings) EIN. : 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231 Type: 6-K | Act: 34 | File No.: 001-40712 | Film No.: 26854057 SIC : 2836 Biological Products, (No Diagnostic Substances) (CF Office: 03 Life Sciences)